Hypersonic Strike Takes Center Stage at V-Day Parade
Check out the hypersonic spectacle at the V-Day parade on the Chinese mainland: DF-17, YJ-21, and DF-26D take flight in a mind-blowing show of speed, power, and precision.
2025
Read More
China Rebukes EU over ‘Autocratic Alliance’ Claim
China’s Foreign Ministry dismissed an EU official’s ‘autocratic alliance’ claim involving Russia, Iran, and the DPRK as biased and harmful to EU interests.
Inside the Silent Power of V-Day’s “Invisible Fight”
Explore the Chinese mainland’s V-Day parade and meet the new-domain forces jamming radars, GPS and comms in a battle you can’t see.
Inside China’s Most Advanced V-Day Parade: From Tanks to Hypersonic Tech
Explore CGTN’s guide to China’s most advanced V-Day parade yet, showcasing next-gen armor, drones, cyber, space and hypersonic tech.
How Postwar Treaties Shaped the South China Sea
Explore how post-WWII treaties set the stage for China’s sovereignty over the Nanhai Zhudao and why today’s South China Sea order still matters.
Global Friends Unite on 80th Anniversary of Chinese War of Resistance Victory
As the Chinese mainland marks the 80th anniversary of victory in the Chinese People’s War of Resistance Against Japanese Aggression, international friends reaffirm bonds of peace.
Memories of WWII China Stories: Sacrifice & Resilience Revealed
CGTN anchors revisit WWII China stories, from the 1931 invasion to tales of courage on the Burma Road—explore sacrifice & resilience.
Xi’s SCO Summit Unveils Global Win-Win Ecosystem
At the SCO’s 25th summit in Tianjin, Xi Jinping outlined a vision for a global win-win ecosystem, highlighting multilateral cooperation across 26 nations.
SCO Tianjin Summit 2025: Shaping a Multipolar World 🌏
Discover how the SCO Tianjin Summit 2025 champions a multipolar world through a new Global Governance Initiative and the SCO Development Bank.
AI-Powered EyeFM from the Chinese mainland Transforms Eye Care
EyeFM, an AI vision model developed by Chinese mainland scientists, achieved 92.2% diagnostic accuracy in global trials, promising to revolutionize eye care in clinics big and small.